Glenoid component loosening is a concern in long term outcome of total shoulder arthroplasty. Unfortunately revision of glenoid loosening remains very challenging regarding bone reconstruction and reimplantation of a glenoid component. A new design metal-back component (Arrow™) seems to get the procedure easier and lead to higly best clinical and radiological results than prior technics. It is a retrospective study of 34 patients operated on for isolated aseptic glenoid component loosening between 1997 and 2007. Glenoid bone loss based on a new classification was rated in 5 degrees. All patients were reviewed at a mean follow up of 34 months (from 12 to 89). Pre and post operatively Constant score and SST have been evaluated. Fluoroscopic views and CT scan have been performed for radiologic assesment. Mean delay for revision surgery was 58 months (from 28 to 134 months). 16 patients underwent only bone graft reconstruction. 18 patients underwent both bone reconstruction and glenoid implant reimplantation. Autolog bone graft (iliac crest) was used in 19 cases, allograft bone in 5 cases, and both autolog and dried bone substitutes in 10 cases. The glenoid component was an uncemented metal-backed in 11 cases, and a polyethylene cemented in 2 cases. The new metal-backed bone ingrowth component is composed with a keel and a winglet securing bone graft fixation and implant stability. For the all cohort Constant score improves of 21 points (from 35 to 56). Gain of pain and active motion is statiscally significative (p<
0.005).Patients who underwent reimplantation of a new glenoid component had a higher clinical result (Constant score: 66) than those who underwent only a bone graft reconstruction (Constant score: 52) in term of pain and active forward elevation as well (p<
0.001). At maximum follow up (32 months) no radiolucent lines or loosening of the new glenoid component was noted. Patients who underwent only bone reconstruction showed a mild glenoid erosion due to subsidence and resorption of cancellous auto or allograft bone. Revision of glenoid component depends on the glenoid bone stock specially about posterior defect. The use of cortical autolog bone graft and new metalback component allows better glenoid reconstruction, secure the stabiliy of the new gle and yields to goods clinical results restoring painless shoulder and function. Reimplantation of a glenoid component becomes an adequate procedure for total shoulder arthroplasty revision
Percutaneos radiofrequency (RF) ablation of osteoid osteoma has been proved as an effective treatment. However, there is limited data regarding other tumors. It also has been described in the treatment of other benign and malignant tumors like chondroblastoma and metastasis. In fact, one of the reported cases of chondroblastoma that were treated with RF was radiological small lesion erroneously diagnosed prior to treatment as osteoid osteomas. It was diagnosed as chondroblastoma only retrospectively. The aim of this study is to describe the success of RF as a definitive treatment and as an alternative to traditional surgery for the treatment of large chondroblastoma and chondromyxoid-fibroma which were diagnosed as such prior to ablation. From April 2006 to April 2007, 3 patients with chondroblastoma and 1 patient with chondromyxoid-fibroma were treated with RF ablation using cool-tip probe. Three procedures were done in the CT suit and one in the operating room. There were 3 girls and 1 boy. Mean age was 12 y 9 m (range 11 y 6 m – 14 y 6 m). Clinical and radiological follow-up was performed to assess outcome. The mean follow-up was 23.25 months (range 20–32 months). Three patients healed after single treatment and one needed repeated treatment. No immediate or delayed complications were observed. Follow up MRI showed no enhancement in the lesion and an extra-lesional sclerotic ream signifying RF effect beyond the lesion area. All patients returned to complete normal painless function. In spite of the small number of patients, percutaneous RF ablation was shown to be an effective and safe minimally invasive procedure for the treatment of chondroblastoma and chondromyxoid-fibroma, avoiding the morbidity of commonly used wide excision surgeries.
Does the pre-operative range of active anterior elevation alter the outcome of reverse shoulder prosthesis? A review of 96 cases.